期刊文献+

人参皂苷Rg1对2型糖尿病大鼠的肾脏保护作用 被引量:3

Effect of Ginsenoside Rg1 on Renal Protection in Type 2 Diabetic Rats
下载PDF
导出
摘要 目的探讨人参皂苷Rg1对2型糖尿病大鼠肾脏的保护作用及机制。方法采用高糖高脂饮食+小剂量链脲佐菌素(STZ)建立2型糖尿病大鼠模型,给予人参皂苷Rg1灌胃4周治疗后,测定血肌酐(Scr)、尿素氮(BUN)、尿酸(UA)。取肾脏组织切片进行HE染色,观察肾脏组织的病理改变;用Westernblot检测大鼠肾脏组织内血管紧张素Ⅱ1型受体(AT1)、转化生长因子-β1(TGF-β1)、金属蛋白酶-9(MMP-9)的表达水平。结果 2型糖尿病大鼠BUN明显高于正常组,但是Scr、UA与正常组比无统计学意义(P> 0.05)。人参皂苷Rg1不同剂量治疗后BUN值下降,二甲双胍组BUN也下降,而Scr、UA变化差异无统计学意义(P> 0.05)。糖尿病大鼠肾系数高于正常组(P <0.05),给与人参皂苷Rg1以及二甲双胍治疗后肾体比下降(P <0.05)。糖尿病大鼠肾脏AT1及TGF-β1表达高于正常组(P <0.05),给与人参皂苷Rg1不同剂量以及二甲双胍治疗后表达降低(P <0.05)。MMP9在糖尿病大鼠肾脏中表达下降,而在人参皂苷Rg1以及二甲双胍治疗后表达增加。结论人参皂苷Rg1能够保护大鼠肾脏受损,其分子机制可能是通过抑制RAS系统激活,抑制TGF-β1的表达,促进细胞外基质的水解,减轻肾脏受损程度。 Objective To investigate the protective effect and mechanism of ginsenoside Rg1 on the kidneys of type 2 diabetic rats.Methods A high-sugar and high-fat diet+low-dose streptozotocin(STZ)was used to establish a type 2 diabetic rat model.Ginsenoside Rg1 was administered to the stomach for 4 weeks,and blood creatinine(Scr)、uric acid(UA)and urea nitrogen(BUN)were measured.Take kidney tissue sections for HE staining to observe the pathological changes of kidney tissue;Western blot was used to detect angiotensinⅡtype 1 receptor(AT1),transforming growth factor-β1(TGF-β1)and metalloproteinase-9 in rat kidney tissue expression level.Results BUN of type 2 diabetic rats was significantly higher than that of the normal group,but Scr and UA were not statistically significant compared with the normal group.After different doses of ginsenoside Rg1,the BUN value decreased,and the BUN of the metformin group also decreased,but there was no statistical difference in the changes of Scr and UA(P>0.05).The renal coefficient of diabetic rats was higher than that of the normal group,and the renal body ratio decreased after treatment with ginsenoside Rg1 and metformin(P<0.05).The expressions of AT1 and TGF-β1 in the kidneys of diabetic rats were higher than those in the normal group,and the expressions decreased after being given different doses of ginsenoside Rg1 and metformin treatment(P<0.05).The expression of MMP9 decreased in the kidneys of diabetic rats,but increased after treatment with ginsenoside Rg1 and metformin(P<0.05).Conclusions Ginsenoside Rg1 can protect the kidney from damage in rats.Its molecular mechanism may be through inhibiting the activation of the RAS system,inhibiting the expression of TGF-β1,promoting the hydrolysis of extracellular matrix,and reducing the degree of kidney damage.
作者 阮愕舒 王烁 苏惠 尹凤琼 钱忠义 杨建宇 RUAN Er-shu;SU Hui;WANG Shuo;YANG Jian-yu;QIAN Zhong-yi;YANG Jian-yu(Dept.of Pharmacology,School of Basic Medicine,Kunming Medical University 650051;Pharmacy Department,Jinan People’s Hospital 271199;Dept.of Neurology,The Second Affiliated Hospital of Kunming Medical University;Experimental Center of Morphology,Kunming Medical University,Kunming Yunnan 650051,China)
出处 《昆明医科大学学报》 CAS 2021年第6期50-55,共6页 Journal of Kunming Medical University
基金 云南省科技厅-昆明医科大学应用基础研究联合专项基金资助项目(2017FE468-206)。
关键词 人参皂苷RG1 2型糖尿病 肾脏RAS系统 对肾的保护作用及机制 Ginsenoside Rg1 Type 2 diabetes RAS system of kidney Protective effect of kidney and mechanism
  • 相关文献

参考文献17

二级参考文献181

共引文献234

同被引文献41

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部